tradingkey.logo
tradingkey.logo
Search

Eikon Therapeutics Ord Shs

EIKN
Add to Watchlist
9.210USD
-0.410-4.26%
Close 07-31 16:00ETQuotes delayed by 15 min
498.62MMarket Cap
LossP/E TTM

Eikon Therapeutics Ord Shs

9.210
-0.410-4.26%

More Details of Eikon Therapeutics Ord Shs Company

Eikon Therapeutics Ord Shs Info

Ticker SymbolEIKN
Company nameEikon Therapeutics Inc
IPO dateFeb 05, 2026
CEOPerlmutter (Roger M)
Number of employees384
Security typeOrdinary Share
Fiscal year-endFeb 05
Address230 Harriet Tubman Way
CityMILLBRAE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94030
Phone13026587581
Websitehttps://eikontx.com/
Ticker SymbolEIKN
IPO dateFeb 05, 2026
CEOPerlmutter (Roger M)

Company Executives of Eikon Therapeutics Ord Shs

Name
Name/Position
Position
Shareholding
Change
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
Mr. Joshua Wolfe
Mr. Joshua Wolfe
Director
Director
--
--
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
Mr. Joshua Wolfe
Mr. Joshua Wolfe
Director
Director
--
--
,
,
--
--

FAQs

Who are the top five shareholders of Eikon Therapeutics Ord Shs?

The top five shareholders of Eikon Therapeutics Ord Shs are: Dr. Roger M. Perlmutter, M.D., Ph.D.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.